DPT Meeting: FDA Opening Remarks AGENDA Opening Remarks Janet Woodcock, MD, U.S. Food and Drug Administration Billy Dunn, MD, U.S. Food and Drug Administration 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 5 years ago You may also like 10:23 Cumberland Pharmaceuticals 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 7:11 Epirium Bio 4 years ago Conferences & Meetings,In the Pipeline: Downstream Targets 18:36 Sarepta Therapeutics (RNA Targeted Therapies) 4 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:46 NS Pharma 4 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 11:20 PTC Therapeutics (Ataluren) 4 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 15:10 Daiichi-Sankyo 4 years ago Conferences & Meetings,In the Pipeline: Restoring Dystrophin 20:43 ReveraGen BioPharma 4 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 12:20 Catabasis 4 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation «1…1920212223…25»Page 21 of 25
by: Parent Project Muscular Dystrophy
